Adams Clinical Philadelphia — Philadelphia, Pennsylvania

Adams Clinical Philadelphia is a clinical research site located in Philadelphia, Pennsylvania, United States 19104.

Crixeo Health Trust Score: 71/100 (FAIR). This profile has not yet been claimed by the site owner.

Adams Clinical Philadelphia has participated in 6 clinical trials with 6 currently active.

Therapeutic areas: Generalized Anxiety Disorder, Opioid Use Disorder, Major Depressive Disorder (MDD).

Sponsors: Definium Therapeutics US, Inc., Eli Lilly and Company, Cybin IRL Limited.

Sponsor Feasibility Report

Trust Score: 71/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Adams Clinical Philadelphia?

Adams Clinical Philadelphia has a Crixeo Trust Score of 71/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Adams Clinical Philadelphia conducted?

Adams Clinical Philadelphia has 6 clinical trials on record, with 6 currently active. Their work covers Generalized Anxiety Disorder, Opioid Use Disorder, Major Depressive Disorder (MDD).

Is Adams Clinical Philadelphia accredited by Crixeo Health?

Yes — Adams Clinical Philadelphia holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Adams Clinical Philadelphia?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.